期刊文献+

短期持续皮下胰岛素输注强化治疗糖尿病的临床观察 被引量:2

Intensive therapy of 15 cases diabetes mellitus with continuous subcutaneous insulin infusion
原文传递
导出
摘要 目的:观察持续皮下胰岛素输注法(CSII)对糖尿病患者强化血糖的控制效果。方法:35例糖尿病患者随机分为CSII组(15例)和常规多次皮下注射法(MDI)组(20例),进行强化胰岛素治疗。结果:CSII组血糖控制达标的时间和胰岛素的用量明显少于MDI组;CSII组的低血糖的发生率较低,并且能较有效地控制黎明现象的发生。结论:CSII是短期糖尿病患者强化血糖控制较理想的方法。 OBJECTIVE To investigate the effect of intensive therapy with continuous subcutaneous insulin infusion(CSII) on diabetes mellitus. METHODS 35 cases diabetes mellitus were randomly divided into CSII group(15 cases) and MDI(multipie daily injection) group(20 cases). RESULTS The time when the goal of boold glucose control was achieved, in CSII group was shorter than in MDI group,and the total insulin dose in CSII group was lower than in MDI group; the rate of hypoglycaemia and down phenomenon in CSII group was lower than in MDI group. CONCLUSION CSII is a ideal method of intensive glucose control in diabetes.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2009年第3期221-223,共3页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献7

  • 1李锐,卢伟,贾伟平,黎衍云,施亮,刘美霞,耿国柱,傅华,施榕,史君衡,史虹莉,张胜年.上海市2型糖尿病患病情况现状调查[J].中华医学杂志,2006,86(24):1675-1680. 被引量:105
  • 2Diabetes Control and Complications Trail (DCCT) Research Group. The effect of intensive treatment of diabetes on the de velopment and progression of long-term complications in insulin-dependent diabetes mellitus[J].The New England Journal of Medicine, 1993,329:977-986.
  • 3Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylur eas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes[J]. Lancet, 1998,352 : 837-853.
  • 4Li Y, Xu W, Liao Z, et al. Induction of long-term glyeemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function [J].Diabetes Care, 2004,27( 11) : 2597-2602.
  • 5Hoogma RP, Hammond PJ, Gomis R,etal. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections(MDI) on glycaemie control and quality of life: results of the 5-nations trial[J]. Diabetes Med,2006,23(2) : 141-147.
  • 6程伟,严钟穗.长效胰岛素类似物的临床研究进展[J].国外医学(内分泌学分册),2003,23(4):237-239. 被引量:28
  • 7Iikova H, Glaster B, Tuncktale A,et al. Induction of long-term glycemic control in newly diagnosed Type 2 diabetic patients by transient intensive insulin treatment[J]. Diabetes Care, 1997, 20:1353- 1356.

二级参考文献28

  • 1青岛市糖尿病流行病学调查组.青岛地区20~74岁人群糖尿病患病率调查[J].中华糖尿病杂志(1006-6187),2004,12(5):344-347. 被引量:50
  • 2贾伟平,潘洁敏,陈蕾,吴元民,陆俊茜,项坤三.空腹血糖受损切点变化与糖尿病及心脑血管事件风险的关系——上海华阳社区40岁以上人群的随访研究[J].中华内分泌代谢杂志,2004,20(5):392-395. 被引量:86
  • 3全国糖尿病研究协作组调查研究组.全国14省市30万人口中糖尿病调查报告[J].中华内科杂志,1981,20(11):678-678.
  • 4Ebeling P, Jansson P A, Smith U, et al. Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin[J]. Diabetes Care, 1997,20 : 1287-1289.
  • 5Rosskamp R H, Park G. Long-acting insulin analogs[J].Diabetes Care,1999, 22(Suppl 2) :B109-B113.
  • 6Vajo Z, Fawcett J, Duckworth W C. Recombinant DNA technology in the treatment of diabetes [ J]. Endocr Rev, 2001,22:706-717.
  • 7McKeage K, Goa K L. Insulin Glargine [ J ]. Drugs, 2001,61 :1599-1624.
  • 8Heinemann L, Linkeschova R, Rave K. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo[J]. Diabetes Care, 2000,23 : 644-649.
  • 9Talaulicar M, Willms B, Rosskamp R. HOE901, ein neues insulin analog zur substitution des basalen insulin-bedarfs bei type 1 diabetes[ J ]. Diabetes Stoffwechsel, 1996,5 : 3-6.
  • 10Ratner R E, Hirsch I B, Neifing J L. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes[J]. Diabetes Care ,2000,23 : 639-643.

共引文献131

同被引文献18

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部